Who Buys Melphalan from India — 272 Importers Behind a $12.8M Market
India's melphalan import market is served by 272 active buyers who collectively imported $12.8M across 838 shipments. FARMAMONDO LLC (RUSSIA) leads with a 21.0% market share, followed by TILLOMED LABORATORIES LTD and TILLOMED LABORATORIES LIMITED. The top 5 buyers together control 51.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Melphalan Importers — Ranked by Import Value
FARMAMONDO LLC (RUSSIA) is the leading melphalan importer from India, holding a 21.0% share of the $12.8M market across 838 shipments from 272 buyers. The top 5 buyers — FARMAMONDO LLC (RUSSIA), TILLOMED LABORATORIES LTD (UNITED KINGDOM), TILLOMED LABORATORIES LIMITED (UNITED KINGDOM), TILLOMED MALTA LTD (MALTA), ACE PHARMA CO. LTD. (SOUTH KOREA) — collectively control 51.2% of total import value.
Top Melphalan Buyers & Importers
Ranked by import value · 272 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | FARMAMONDO LLCRUSSIA PHARMA: MEGVAL INJECTION (MELPHALAN HYDRMELPHASE INJECTION MELPHALAN 50MG INJECTION 1 SMELPHALAN FOR INJECTION BP 50MG/VIAL (ME | $2.7M | 5 | 21.0% |
| 2 | TILLOMED LABORATORIES LTDUNITED KINGDOM MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $1.6M | 5 | 12.2% |
| 3 | TILLOMED LABORATORIES LIMITEDUNITED KINGDOM MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $987.5K | 5 | 7.7% |
| 4 | TILLOMED MALTA LTDMALTA MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $735.4K | 5 | 5.8% |
| 5 | ACE PHARMA CO. LTD.SOUTH KOREA MELPHALAN HCL FOR INJECTION 50MG/VIALPHARMACEUTICALS PRODUCTSMEGVAL 50MG INJ 1VIALTARO-MELPHALAN HCL FOR INJECTION 50MG/VIAL | $566.4K | 5 | 4.4% |
| 6 | TILLOMED MALTA LIMITEDMALTA MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $475.7K | 5 | 3.7% |
| 7 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM MELPHALAN SUN INJ 50MG 1'S VL DE PACK :1 VIAL NOSMELPHALAN SUN INJ 50MG 1'S VL IT PACK :1 VIAL NOS | $436.9K | 5 | 3.4% |
| 8 | MARCAN PHARMACEUTICALS INCCANADA TARO-MELPHALAN HCL FOR INJECTION 50MG/VIALMELPHALAN INJECTION 50 MG VIAL NO.OFVIALS 5000MELPHALAN FOR INJ 50MG 2.5ML FIL MAR CANO OF VIALS 4990 | $406.8K | 5 | 3.2% |
| 9 | ARABIAN HEALTH CARE SUPPLY CO.SAUDI ARABIA PHARMACEUTICALS PRODUCTS: MEGVAL 50 MG INJ 1 VIALPHARMA: MEGVAL INJECTION (MELPHALAN HYDRPHARMA: MEGVAL 50MG INJECTION-1VIALVLS | $232.7K | 5 | 1.8% |
| 10 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAANBELGIUM MELPHALAN SUN INJ 50MG 1'S VL DE PACK :1 VIAL NOSMELPHALAN SUN INJ 50MG 1'S VL IT PACK :1 VIAL NOS | $216.3K | 5 | 1.7% |
| 11 | TARO PHARMACEUTICALS INC.CANADA TARO-MELPHALAN HCL FOR INJECTION 50MG/VIALMELPHALAN INJECTION 50 MG VIAL NO.OFVIALS 5000MELPHALAN FOR INJ 50MG 2.5ML FIL MAR CANO OF VIALS 4990 | $193.5K | 5 | 1.5% |
| 12 | SENT PHARMA LTDTURKEY MELP SPAL 50MELPHALAN HYDROCHLORIDE FOR INJECTIONMELKERAN 2MG 25TAB MELPHALAN TABLETS | $169.7K | 5 | 1.3% |
| 13 | ALLIANCE PHARMA CO., LTD.THAILAND | $167.2K | 5 | 1.3% |
| 14 | TILLOMED LABORATORIES LTD ,,,UNITED KINGDOM MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $166.1K | 5 | 1.3% |
| 15 | TILLOMED ITALY SRLITALY MEDICINES MELPHALAN 50MG 2.5ML FIL INJMEDICINES MELPHALAN INJ 50MG 2.5ML FIL I | $125.6K | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Melphalan — and from which countries?
Flow of Melphalan exports from India: each country's share and the named importers behind the numbers
Melphalan — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia emerges as the first largest importing country, achieving a total trade value of $3.0M through 5 shipments. This represents a market share of 23.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• FARMAMONDO LLC - $2.7M (89.6% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $598.1K, indicating premium pricing strategy compared to the market average of $15.2K.
Russia is a key market for Melphalan imports, representing 23.4% of total trade value.
2United Kingdom
United Kingdom emerges as the second largest importing country, achieving a total trade value of $2.7M through 78 shipments. This represents a market share of 21.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• TILLOMED LABORATORIES LTD - $1.6M (57.4% of country's total business)
• TILLOMED LABORATORIES LIMITED - $987.5K (36.4% of country's total business)
• TILLOMED LABORATORIES LTD ,,, - $166.1K (6.1% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $34.8K, indicating premium pricing strategy compared to the market average of $15.2K.
United Kingdom is a key market for Melphalan imports, representing 21.3% of total trade value.
3Malta
Malta emerges as the third largest importing country, achieving a total trade value of $1.2M through 50 shipments. This represents a market share of 9.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• TILLOMED MALTA LTD - $735.4K (60.7% of country's total business)
• TILLOMED MALTA LIMITED - $475.7K (39.3% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $24.2K, indicating premium pricing strategy compared to the market average of $15.2K.
Malta is a key market for Melphalan imports, representing 9.5% of total trade value.
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $978.9K through 5 shipments. This represents a market share of 7.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MARCAN PHARMACEUTICALS INC - $406.8K (41.6% of country's total business)
• TARO PHARMACEUTICALS INC. - $193.5K (19.8% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $195.8K, indicating premium pricing strategy compared to the market average of $15.2K.
Canada is a key market for Melphalan imports, representing 7.7% of total trade value.
5United States
United States emerges as the fifth largest importing country, achieving a total trade value of $968.4K through 0 shipments. This represents a market share of 7.6% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: United States demonstrates strong market positioning with an average shipment value of $968.4K, indicating premium pricing strategy compared to the market average of $15.2K.
United States is a key market for Melphalan imports, representing 7.6% of total trade value.
Buyer Segment Analysis
TransData Nexus Melphalan buyer market intelligence
1Buyer Segment Analysis
The importation of Melphalan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like FARMAMONDO LLC (Russia) and ACE PHARMA CO. LTD. (South Korea) function as intermediaries, procuring Melphalan in bulk to supply to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Contract Manufacturers: Companies such as TILLOMED LABORATORIES LTD and TILLOMED LABORATORIES LIMITED (both United Kingdom) and TILLOMED MALTA LTD and TILLOMED MALTA LIMITED (both Malta) likely engage in contract manufacturing. They import Melphalan as an active pharmaceutical ingredient (API) for formulation and packaging, often for re-export. Their procurement is typically project-based, aligning with production schedules and client demands.
- Logistics Providers: YUSEN LOGISTICS BENELUX BELGIUM (Belgium) appears to act as a logistics provider, facilitating the transportation and distribution of Melphalan. Their involvement suggests a role in managing the supply chain rather than direct procurement for end-use.
Understanding these segments is crucial for tailoring market strategies, as each has unique needs and procurement behaviors.
Country-Specific Import Regulations
TransData Nexus Melphalan buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Melphalan vary across the top importing countries:
- Russia:
- Regulatory Authority: Ministry of Health of the Russian Federation.
- Import Registration Process: Requires submission of a registration dossier, including clinical data and quality documentation.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Post-Brexit, the UK requires a separate marketing authorization; applications must include comprehensive data on safety, efficacy, and quality.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; however, specific duties may apply based on trade agreements.
- Malta:
- Regulatory Authority: Malta Medicines Authority.
- Import Registration Process: As an EU member, Malta follows the European Medicines Agency (EMA) centralized procedure or national procedures for marketing authorization.
- Estimated Timeline: Approximately 12-15 months.
- Import Tariff/Duty: 0% for pharmaceuticals under EU regulations.
- Canada:
- Regulatory Authority: Health Canada.
- Import Registration Process: Requires a Drug Identification Number (DIN) through the New Drug Submission (NDS) process, including detailed clinical and quality data.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; specific conditions may apply.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Requires approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), with comprehensive data on safety, efficacy, and manufacturing.
- Estimated Timeline: Approximately 12-24 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; specific conditions may apply.
Navigating these regulatory landscapes is essential for successful market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Melphalan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Melphalan is primarily driven by its critical role in treating multiple myeloma and ovarian cancer. The inclusion of Melphalan in the WHO Model List of Essential Medicines underscores its importance in global health.
Government healthcare programs and the expansion of universal health coverage in various countries have increased access to essential medicines, including Melphalan. Tender-based procurement processes, often influenced by the WHO Essential Medicines List, facilitate bulk purchasing, ensuring consistent supply and affordability. The presence of 272 buyers across 97 countries indicates a broad and sustained global demand, presenting significant market opportunities for suppliers.
Common Questions — Melphalan Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest melphalan buyer importing from India?
Based on import volume and value, FARMAMONDO LLC (RUSSIA) leads with $2.7M in imports and a 21.0% market share — the highest of any single melphalan importer. TILLOMED LABORATORIES LTD (UNITED KINGDOM) and TILLOMED LABORATORIES LIMITED (UNITED KINGDOM) are the next largest buyers.
QHow many companies buy melphalan from India?
There are 272 active melphalan buyers importing from India, with a combined market of $12.8M across 838 shipments to 97 countries. The top 5 buyers hold 51.2% of total import value, while the remaining 267 buyers handle the other 48.8%.
QWhich countries import the most melphalan from India?
The top importing countries for melphalan from India are Russia (23.4%), United Kingdom (21.3%), Malta (9.5%), Canada (7.7%), United States (7.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of melphalan, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for melphalan from India?
The average import transaction value for melphalan from India is $15.2K, with an average unit price of $19.81 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Melphalan buyer market intelligence
1Buyer Segment Analysis
The importation of Melphalan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like FARMAMONDO LLC (Russia) and ACE PHARMA CO. LTD. (South Korea) function as intermediaries, procuring Melphalan in bulk to supply to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Contract Manufacturers: Companies such as TILLOMED LABORATORIES LTD and TILLOMED LABORATORIES LIMITED (both United Kingdom) and TILLOMED MALTA LTD and TILLOMED MALTA LIMITED (both Malta) likely engage in contract manufacturing. They import Melphalan as an active pharmaceutical ingredient (API) for formulation and packaging, often for re-export. Their procurement is typically project-based, aligning with production schedules and client demands.
- Logistics Providers: YUSEN LOGISTICS BENELUX BELGIUM (Belgium) appears to act as a logistics provider, facilitating the transportation and distribution of Melphalan. Their involvement suggests a role in managing the supply chain rather than direct procurement for end-use.
Understanding these segments is crucial for tailoring market strategies, as each has unique needs and procurement behaviors.
Country-Specific Import Regulations
TransData Nexus Melphalan buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Melphalan vary across the top importing countries:
- Russia:
- Regulatory Authority: Ministry of Health of the Russian Federation.
- Import Registration Process: Requires submission of a registration dossier, including clinical data and quality documentation.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Typically ranges from 5% to 10% for pharmaceuticals under HS Code 30049049.
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Post-Brexit, the UK requires a separate marketing authorization; applications must include comprehensive data on safety, efficacy, and quality.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; however, specific duties may apply based on trade agreements.
- Malta:
- Regulatory Authority: Malta Medicines Authority.
- Import Registration Process: As an EU member, Malta follows the European Medicines Agency (EMA) centralized procedure or national procedures for marketing authorization.
- Estimated Timeline: Approximately 12-15 months.
- Import Tariff/Duty: 0% for pharmaceuticals under EU regulations.
- Canada:
- Regulatory Authority: Health Canada.
- Import Registration Process: Requires a Drug Identification Number (DIN) through the New Drug Submission (NDS) process, including detailed clinical and quality data.
- Estimated Timeline: Approximately 12-18 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; specific conditions may apply.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Requires approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), with comprehensive data on safety, efficacy, and manufacturing.
- Estimated Timeline: Approximately 12-24 months.
- Import Tariff/Duty: Generally 0% for pharmaceuticals; specific conditions may apply.
Navigating these regulatory landscapes is essential for successful market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Melphalan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Melphalan is primarily driven by its critical role in treating multiple myeloma and ovarian cancer. The inclusion of Melphalan in the WHO Model List of Essential Medicines underscores its importance in global health.
Government healthcare programs and the expansion of universal health coverage in various countries have increased access to essential medicines, including Melphalan. Tender-based procurement processes, often influenced by the WHO Essential Medicines List, facilitate bulk purchasing, ensuring consistent supply and affordability. The presence of 272 buyers across 97 countries indicates a broad and sustained global demand, presenting significant market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 272 global importers of Melphalan identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 838 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 97 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
838 Verified Shipments
272 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists